Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-24-000265

Director sold 73,730 shares at an average $243.93 ($17,984,804)

  • Director acquired 73,730 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FRIEDMAN PAUL A Director 2024-04-03 Option exercise 10b5-1 +27,407 $9.45 $258,996 213,142 D
FRIEDMAN PAUL A Director 2024-04-03 Sale 10b5-1 −185 $242.00 $44,770 212,957 D
FRIEDMAN PAUL A Director 2024-04-03 Sale 10b5-1 −2,294 $243.64 $558,921 210,663 D
FRIEDMAN PAUL A Director 2024-04-03 Sale 10b5-1 −4,301 $244.58 $1,051,959 206,362 D
FRIEDMAN PAUL A Director 2024-04-03 Sale 10b5-1 −18,806 $245.34 $4,613,823 187,556 D
FRIEDMAN PAUL A Director 2024-04-03 Sale 10b5-1 −1,821 $246.31 $448,530 185,735 D
FRIEDMAN PAUL A Director 2024-04-04 Option exercise 10b5-1 +18,710 $9.45 $176,810 204,445 D
FRIEDMAN PAUL A Director 2024-04-04 Sale 10b5-1 −6,273 $241.07 $1,512,222 198,172 D
FRIEDMAN PAUL A Director 2024-04-04 Sale 10b5-1 −5,299 $242.25 $1,283,679 192,873 D
FRIEDMAN PAUL A Director 2024-04-04 Sale 10b5-1 −1,467 $243.00 $356,482 191,406 D
FRIEDMAN PAUL A Director 2024-04-04 Sale 10b5-1 −627 $244.31 $153,185 190,779 D
FRIEDMAN PAUL A Director 2024-04-04 Sale 10b5-1 −2,549 $245.14 $624,857 188,230 D
FRIEDMAN PAUL A Director 2024-04-04 Sale 10b5-1 −1,558 $246.13 $383,471 186,672 D
FRIEDMAN PAUL A Director 2024-04-04 Sale 10b5-1 −737 $247.14 $182,141 185,935 D
FRIEDMAN PAUL A Director 2024-04-04 Sale 10b5-1 −200 $248.43 $49,685 185,735 D
FRIEDMAN PAUL A Director 2024-04-05 Option exercise 10b5-1 +27,613 $9.45 $260,943 213,348 D
FRIEDMAN PAUL A Director 2024-04-05 Sale 10b5-1 −1,420 $240.10 $340,939 211,928 D
FRIEDMAN PAUL A Director 2024-04-05 Sale 10b5-1 −612 $241.15 $147,582 211,316 D
FRIEDMAN PAUL A Director 2024-04-05 Sale 10b5-1 −6,679 $242.42 $1,619,098 204,637 D
FRIEDMAN PAUL A Director 2024-04-05 Sale 10b5-1 −9,264 $243.20 $2,253,016 195,373 D
FRIEDMAN PAUL A Director 2024-04-05 Sale 10b5-1 −3,966 $244.22 $968,588 191,407 D
FRIEDMAN PAUL A Director 2024-04-05 Sale 10b5-1 −5,228 $245.35 $1,282,669 186,179 D
FRIEDMAN PAUL A Director 2024-04-05 Sale 10b5-1 −444 $245.92 $109,189 185,735 D
Derivatives
FRIEDMAN PAUL A Director 2024-04-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −27,407 278,849 D
FRIEDMAN PAUL A Director 2024-04-04 Option exercise · Stock Option (Right to Buy) 10b5-1 −18,710 260,139 D
FRIEDMAN PAUL A Director 2024-04-05 Option exercise · Stock Option (Right to Buy) 10b5-1 −27,613 232,526 D
Open-market sales · 73,730 sh · avg $243.93 · $17,984,804
Loading xslF345X05/doc4.xml…